PMC9975343_01
Graphical representation of laboratory values and therapeutical interventions during the course of the disease. R, ravulizumab; TPE, therapeutic plasma exchange; RBC, red blood cells; PLT, platelets.
fped-11-1092860-g001.jpg
PMC9975343_01_fped-11-1092860-g001.jpg
F1
Interestingly, this led to the progressive amelioration of the patient's clinical and laboratory findings (Figure 1), so he was discharged from the hospital after 20 days of treatment and two Ravulizumab applications. Hb 126 g/L, Htc 0.361, PLT 290 x 109, LDH 275 U/L, and haptoglobin 0.78 g/L. His urea was 4.8 mmol/L, serum creatinine, 25 micromol/L while urine laboratory findings were completely normal (Figure 1).